Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lymphoma
Biotech
Galapagos drops one CD19 CAR-T to focus on 'flagship' program
Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s seemingly never-ended work to recalibrate the business.
James Waldron
Feb 13, 2025 8:00am
RTW-built biotech's $520M deal for InnoCare, Keymed bispecific
Jan 21, 2025 4:32am
Cash-strapped Viracta ends phase 2 study of lead cancer drug
Jan 2, 2025 7:41am
Nkarta continues pivot to lupus by shelving lymphoma program
Nov 8, 2024 8:55am
Viracta begins 2nd round of layoffs in 3 months
Nov 7, 2024 5:02am
Viracta axes staff to slim down for race to cancer finish line
Aug 14, 2024 8:09am
